The Irish GLP-1 landscape: whats approved and what isnt Not all GLP-1 medications are created equal in the eyes of Irish regulators, and this is the first confusion most patients have
When using virtual care, all medical treatment is at the sole discretion of the provider
Instead, they are often searching for solutions to symptoms that have gradually developed over time
Quick Take & Core Data: Average body weight reduction: 30.3% at 104 weeks [1] Dose cohort outcome: 45% of patients in the 12 mg group lost 30% or more body weight [1] Diabetic weight loss efficacy: 16.8% reduction over 40 weeks [2] Retatrutide is a triple agonist that binds directly to three metabolic pathways [1, 3]
Moreover, Pereira et al
The hypothetical benefits include reduction of inflammation, improved liver function, increased energy, relief of constipation, IBS, and candida